
Results
11
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
11 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩393,000.00
7D
-5.8%
1Y
-41.8%
ST PharmLtd
Market Cap: ₩2.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩100,300.00
7D
-7.1%
1Y
12.2%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩36,600.00
7D
-2.1%
1Y
8.6%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩118,500.00
7D
-8.9%
1Y
-10.9%
Boryung
Market Cap: ₩760.3b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,000.00
7D
-2.5%
1Y
8.4%
JW Holdings
Market Cap: ₩282.0b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,075.00
7D
0.4%
1Y
22.2%
Chong Kun Dang Holdings
Market Cap: ₩191.4b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩40,200.00
7D
-0.9%
1Y
-14.8%
Ilyang PharmaceuticalLtd
Market Cap: ₩156.3b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,720.00
7D
-3.0%
1Y
-31.7%
Sinsin Pharmaceutical
Market Cap: ₩68.9b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,540.00
7D
2.3%
1Y
-18.8%
RP Bio
Market Cap: ₩51.9b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩5,990.00
7D
-6.8%
1Y
-8.5%
Korean Drug
Market Cap: ₩36.9b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,380.00
7D
-3.6%
1Y
-27.8%